$3.80
0.061.59%
Pre-Market: Jul 19, 7:57 AM EDT
15 minutes delayed
Comments
Loading...
Tharimmune
THARNASDAQ
Tharimmune (NASDAQ:THAR) Stock Quotes, Forecast and News Summary
Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 44.34K |
| Day Range | - - - |
| 52 Wk Range | 2.75 - 2.14K |
| Market Cap | $2.99M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 24 |
| Short Interest | 6.48% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Tharimmune Inc
Sector
Health Care
Industry
Biotechnology
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tharimmune (THAR) stock?
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Who are Tharimmune (THAR) competitors?
Other companies in Tharimmune’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the target price for Tharimmune (THAR) stock?
There is no analysis for Tharimmune.
What is the forecast for Tharimmune (THAR) stock?
There is no analysis for Tharimmune to provide a consensus price target.
Current stock price for Tharimmune (THAR)?
The stock price for Tharimmune (NASDAQ: THAR) is $3.8 last updated July 19, 2024 at 7:57 AM EDT.
Does Tharimmune (THAR) pay a dividend?
There are no upcoming dividends for Tharimmune.
When is Tharimmune (NASDAQ:THAR) reporting earnings?
Tharimmune’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Tharimmune (THAR) going to split?
There is no upcoming split for Tharimmune.
What sector and industry does Tharimmune (THAR) operate in?
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.